We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIG
1026
DELISTED
Big Lots, Inc.
BIG
$279K 0.01%
5,554
+33
+0.6% +$1.62K
LDOS icon
1027
Leidos
LDOS
$14.5B
$277K 0.01%
+5,415
New +$253K
YELP icon
1028
Yelp
YELP
$1.45B
$277K 0.01%
7,249
-1,540
-18% -$56.9K
NICE icon
1029
Nice
NICE
$5.79B
$275K 0.01%
4,000
-24
-0.6% -$1.6K
SQM icon
1030
Sociedad Química y Minera de Chile
SQM
$19.2B
$275K 0.01%
+9,593
New +$273K
AVP
1031
DELISTED
Avon Products, Inc.
AVP
$275K 0.01%
54,646
+34,998
+178% +$203K
P
1032
DELISTED
Pandora Media Inc
P
$275K 0.01%
21,125
+8,850
+72% +$110K
BSCK
1033
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$274K 0.01%
+12,934
New +$277K
ANGL icon
1034
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.08B
$273K 0.01%
9,500
+2,100
+28% +$60.5K
WSTC
1035
DELISTED
West Corporation
WSTC
$273K 0.01%
11,000
VAW icon
1036
Vanguard Materials ETF
VAW
$2.95B
$272K 0.01%
+2,418
New +$264K
CVA
1037
DELISTED
Covanta Holding Corporation
CVA
$272K 0.01%
17,412
-6,837
-28% -$102K
HZNP
1038
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$272K 0.01%
16,797
-11,200
-40% -$203K
BWLD
1039
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$272K 0.01%
1,763
-499
-22% -$77.6K
ACH
1040
Accendra Health
ACH
$237M
$271K 0.01%
7,663
+330
+5% +$11.2K
FPE icon
1041
First Trust Preferred Securities and Income ETF
FPE
$6.32B
$270K 0.01%
14,243
+1,463
+11% +$28.1K
SURE icon
1042
AdvisorShares Insider Advantage ETF
SURE
$56.6M
$269K 0.01%
+4,239
New +$261K
IYM icon
1043
iShares US Basic Materials ETF
IYM
$1.12B
$268K 0.01%
3,228
-161
-5% -$13K
MTX icon
1044
Minerals Technologies
MTX
$2.36B
$268K 0.01%
3,475
CHK
1045
DELISTED
Chesapeake Energy Corporation
CHK
$268K 0.01%
191
-76
-28% -$99.3K
AZN icon
1046
AstraZeneca
AZN
$263B
$267K 0.01%
4,877
-14,859
-75% -$844K
SAM icon
1047
Boston Beer
SAM
$1.91B
$267K 0.01%
1,572
-605
-28% -$100K
SONY icon
1048
Sony
SONY
$137B
$267K 0.01%
47,660
+2,935
+7% +$17.8K
HOG icon
1049
Harley-Davidson
HOG
$2.58B
$266K 0.01%
4,572
-13,091
-74% -$747K
DG icon
1050
Dollar General
DG
$28B
$265K 0.01%
3,585
-201
-5% -$14.7K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.